- AMGN +0.27%
Search results
- 300.30Add to watchlist+0.82 (+0.27%)At close:4:00 PM EDTTue. May 7, 2024301.00 +0.70 (+0.23%)After hrs:7:23 PM EDTTue. May 7, 2024Nasdaq Real Time Price (USD) · Market closed
- Open301.75High302.91Low298.51
- Mkt Cap161.09BP/E (TTM)42.84Div & Yield9.00 & 3.00%
- Prev. Close299.4852 Wk. Low211.7152 Wk. High329.72
What analysts are sayingTop storiesAmgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on ItYahoo Finance · 12 hours agoInvestors Pile Into Amgen in Search of Next Obesity Drug PayoutYahoo Finance · 2 days agoAmgen Is 'Very Encouraged' With Its Obesity Drug. But Can It Take On Novo, Lilly Duopoly?Investor's Business Daily · 4 days agoRelated stocks
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and ...
Live. Win. Thrive. We dare to ask questions that lead to lifesaving treatments. Join us in pushing the boundaries of biotechnology in a career at Amgen.
Amgen is a pioneer in the science of using living cells to make biologic medicines. We helped invent the processes and tools that built the global biotech industry—turning it into a leading source of therapies for patients.
Amgen Worldwide. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world. GLOBAL PRESENCE. MORE FROM AMGEN.
Jan 31, 2023 · THOUSAND OAKS, Calif., Jan. 31, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced AMJEVITA™ (adalimumab-atto), a biosimilar to Humira ®* (adalimumab), is now available in the United States. AMJEVITA was the first biosimilar to Humira approved by the U.S. Food and Drug Administration (FDA), in 2016. 2,3.
Corporate Headquarters. One Amgen Center Drive. Thousand Oaks, CA. 91320-1799. +1 805-447-1000.
Amgen | 1,190,102 followers on LinkedIn. #WeareBiotech | Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing ...